FDA Update on Rituximab & Etanercept; Plus New ACP Gout Guideline

Michele B. Kaufman, PharmD, CGP, RPh, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

References

Genentech Inc. News release: Genentech showcases new clinical data across a variety of blood diseases at American Society of Hematology 2016 Annual Meeting. 2016 Nov 3.
Amgen Inc. News release: FDA approves expanded use of Enbrel (etanercept) to treat children with chronic moderate to severe plaque psoriasis. FirstWord Pharma. 2016 Nov 4.
Qaseem A, Harris RP, Forciea MA, Clinical Guidelines Committee of the American College of Physicians. Management of acute and recurrent gout: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016 Nov 1. doi: 10.7326/M16-0570. [Epub ahead of print]

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

In 1982, my wife (also a rheumatologist) and I attended our first American Rheumatism Association (now the ACR) national meeting. After the meeting we stayed with a friend in a suburb of Boston, where we also had the opportunity to meet our hostess’ in-laws, a retired general practitioner and his wife. When her father-in-law shook…

Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

Rheumatology Drugs at a Glance, Part 2: Psoriasis

ACR Recommends You Treat the Symptoms for Gout Patients

Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

Related Articles